Targeting Better Surgery Options for Advanced Ovarian Cancer Patients
NCT04575935 · RecruitingThis trial looks at two types of surgery for women with advanced ovarian cancer. One method is minimally invasive surgery (MIS), which uses small cuts and aims to reduce pain and recovery time. The other method is laparotomy, a more traditional surgery that involves larger cuts. The goal is to see if MIS is just as good as laparotomy in helping patients stay healthy and live well after surgery.
Locations and contact
This trial is running at 19 locations in 5 countries. 18 of them are currently recruiting.
United States13 locations · 12 recruiting
- Cleveland ClinicCleveland, OhioRecruiting
- Cleveland Clinic Foundation - FloridaWeston, FloridaRecruiting
- Columbia University Medical CenterNew York, New YorkRecruiting
- Dana Farber Cancer InstituteBoston, MassachusettsRecruiting
- DukeDurham, North CarolinaRecruiting
- Houston MethodistHouston, TexasRecruiting
- Lyndon Baines Johnson GeneralHouston, TexasRecruiting
- M D Anderson Cancer CenterHouston, TexasRecruiting
- Massachusetts General HospitalBoston, MassachusettsRecruiting
- NYU Langone HealthMineola, New YorkRecruiting
- St. Luke's University Health NetworkBethlehem, PennsylvaniaRecruiting
- University of Miami Miller School of Medicine-Sylvester Cancer CenterMiami, FloridaRecruiting
- University of Wisconsin Carbone Cancer CenterMadison, WisconsinActive Not Recruiting
Canada2 locations · 2 recruiting
- Arthur J.E. Child Comprehensive Cancer Centre - CalgaryCalgaryRecruiting
- University Health Network - Princess Margaret Cancer CentreTorontoRecruiting
Italy2 locations · 2 recruiting
- Fondazione Policlinico Universitario Agostino Gemelli IRCCSRomeRecruiting
- Sant'Orsola Hospital di BolognaBolognaRecruiting
Mexico1 location · 1 recruiting
- Instituto Nacional de Cancerología (Mexico)TlalpanRecruiting
Netherlands1 location · 1 recruiting
- Amsterdam UMC - Locatie AMC | H5Zuid 154AmsterdamRecruiting
Who can join
Women aged 18 and older can join if they have stage IIIC or IV ovarian, fallopian tube, or primary peritoneal cancer. They should have completed 3 to 4 cycles of chemotherapy and be considered surgical candidates. The trial team will check all eligibility requirements before anyone joins.
What happens during the trial
Participants will be randomly placed in one of two groups. In Arm A, they will have minimally invasive surgery followed by standard chemotherapy. In Arm B, they will have laparotomy followed by the same chemotherapy. Everyone in the trial will receive chemotherapy after their surgery.
The trial team
The trial is sponsored by M.D. Anderson Cancer Center. The principal investigator is Dr. Jose A Rauh-Hain. The National Cancer Institute also collaborates on this study.
Important dates
The trial started on August 5, 2020, and is expected to finish by December 31, 2028. It is currently recruiting new participants.
Additional information
The trial's ID number is NCT04575935. This is a Phase 3 trial, which means it is looking at how well the treatments work and how safe they are. The trial is FDA-regulated and aims to include about 580 participants.
Other recruiting trials for the same condition, with the eligibility rules written in plain language.
Browse similar trials →Find a top oncologist who can tell you whether a trial is a sensible option for you.
Find a doctor →The cancer centers running studies like this one, and what each is known for.
Browse hospitals →